Skip to main content
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
16.03
-0.51 (-3.08%)
Sep 20, 2024, 4:00 PM EDT - Market closed

Cartesian Therapeutics Revenue

Cartesian Therapeutics had revenue of $33.45M in the quarter ending June 30, 2024, with 463.24% growth. This brings the company's revenue in the last twelve months to $54.10M. In the year 2023, Cartesian Therapeutics had annual revenue of $26.00M, down -76.53%.

Revenue (ttm)
$54.10M
Revenue Growth
-76.53%
P/S Ratio
2.49
Revenue / Employee
$1,423,737
Employees
38
Market Cap
342.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

RNAC News

More News